STAA (STAA) revenue breakdown
By product, IOLs is the largest at 62% of fiscal 2020 revenue; Other surgical products grew fastest, 24% a year over 4 years.
By region, Other is the largest at 38% of fiscal 2018 revenue; China grew fastest, 66% a year over 2 years.
Revenue by product
Fiscal years, as STAA reports them in its 10-K filings; fiscal 2020 total $22M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | Share |
|---|---|---|---|---|---|---|
| IOLs | $20M | $17M | $16M | $16M | $14M | 62% |
| Other surgical products | $4M | $5M | $7M | $5M | $8M | 38% |
Revenue by region
Fiscal years, as STAA reports them in its 10-K filings; fiscal 2018 total $124M.
| Regions | 2016 | 2017 | 2018 | Share |
|---|---|---|---|---|
| Other | $39M | $40M | $47M | 38% |
| China | $17M | $24M | $46M | 37% |
| JAPAN | $17M | $18M | $23M | 19% |
| US | $10M | $8M | $7M | 6% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for STAA.
Open STAA in InvestinglyQuestions
Where does STAA make its money?
In fiscal 2020, by product: IOLs $14M, Other surgical products $8M.
From STAA's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.